Search

During the early days of the COVID-19 outbreak, a team of radiation oncologists specializing in breast cancer management at Memorial Sloan Kettering Cancer Center reviewed the literature and established recommendations for the safe use of hypofractionated and abbreviated radiation regimens for our patients with breast cancer.

… Monday, May 11, 2020 As governments and health authorities restrict in-person interactions to contain the spread of COVID-19, radiation oncologists must make unprecedented decisions on behalf of patients needing radiotherapy. We must balance the risk of presenting for treatment with being exposed to

Learn about immunotherapy advances for cancer treatment from Dr. Selwyn Vickers, President and CEO of Memorial Sloan Kettering.

… Tuesday, November 7, 2023 Dear MSK Community, Every day we are inspired when our patients are given new hope, thanks to a lifesaving approach to cancer treatment that was pioneered at MSK — immunotherapy . The premise is straightforward: Encourage a person’s own immune system to overpower cancer cells

MSK physicians and scientists are involved in notable research to be presented during the virtual meeting.

… Friday, September 18, 2020 Thousands of oncology experts from around the world will tune in September 19 to 21 for the European Society for Medical Oncology’s (ESMO) Virtual Congress. During the virtual meeting, experts will present promising new developments aimed at improving cancer patient care. This

Doctors from MSK share tips on how to use AI chatbots to get reliable medical information — and explain why you should still rely on your care team to provide advice that is most relevant to you.

… Tuesday, March 17, 2026 If you’ve ever turned to a chatbot to ask questions about your health, you’re in good company. Millions of Americans now go online every day to seek medical advice from chatbots powered by artificial intelligence (AI). People have been Googling their symptoms for decades, but

New MSK research developed CAR T cells that target two acute myeloid leukemia-specific antigens; shed new light on a genetic element called LINE-1, opening the door to new treatments; identified a key regulator of blood stem cell fate; and found an immunotherapy technique using antibodies that target CD47 shows promise in mice.

… Friday, December 29, 2023 New research from Memorial Sloan Kettering Cancer Center (MSK) developed CAR T cells that target two acute myeloid leukemia-specific antigens; shed new light on a genetic element called LINE-1, opening the door to new treatments; identified a key regulator of blood stem cell

Concerns around COVID-19 are common in the general population, but cancer patients are also balancing questions about what the pandemic means for their treatment, prognosis, and vulnerability to the virus.

… Wednesday, May 27, 2020 Concerns around COVID-19 are common in the general population, but cancer patients are also balancing questions about what the pandemic means for their treatment, prognosis, and vulnerability to the virus. A recent segment featuring Memorial Sloan Kettering (MSK) on NBC News’

Every December for almost 30 years, MSK locksmith Vincent “Vinny” Fortunato has dressed up as Santa Claus to spread holiday cheer to patients and their family members.

… Monday, December 24, 2018 VIDEO | Santa Visits MSK Patients and Staff Vinny Fortunato, a locksmith at MSK, has been dressing up as Santa for 17 years. Watch him as he visits patients and staff. Video Details Summary Every December for almost 30 years, MSK locksmith Vincent “Vinny” Fortunato has dressed

Damon Reed, MD, has joined Memorial Sloan Kettering Cancer Center (MSK) as the inaugural Head of the Division of Pediatric Solid Tumors and as Chief of the Pediatric Sarcoma Service. Dr. Reed is a distinguished oncologist who has dedicated his career to cancer care for children, adolescents, and young adults. A gifted clinician-investigator, he is known for his work in advancing sarcoma clinical research.

… Monday, August 7, 2023 Damon Reed, MD , has joined Memorial Sloan Kettering Cancer Center (MSK) as the inaugural Head of the Division of Pediatric Solid Tumors and as Chief of the Pediatric Sarcoma Service. Dr. Reed is a distinguished oncologist who has dedicated his career to cancer care for children

Meet MSK Chaplain Yusuf Hasan: “I get a great blessing from sitting at the bedside of the sickest of the sick and making sure to see them as human beings, not just an illness.”

… Friday, June 6, 2025 Imam Yusuf Hasan had never heard of MSK in 1991, when he was asked to visit a Muslim patient who was dying of cancer. But he knew there was a need. There were no Muslim chaplains on MSK’s Healthcare Chaplaincy team until he came along to fill that void. He’s remained at MSK supporting

MSK researchers have shown for the first time that the concentration of different types of immune cells in the blood changes in relation to the presence of different bacterial strains in the gut.

… Wednesday, November 25, 2020 Summary MSK researchers have uncovered an important finding about the relationship between the microbiota and the immune system, showing for the first time that the concentration of different types of immune cells in the blood changes in relation to the presence of different